封面
市場調查報告書
商品編碼
2067758

全球快速微生物檢測市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Rapid Microbiology Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 282 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球快速微生物檢測市場預計將從2025年的66.4億美元成長至2034年的149.7億美元,2026年至2034年的複合年成長率(CAGR)為9.45%。該市場穩步成長的原因是醫療、食品、製藥和環境等行業對更快、更準確的微生物檢測解決方案的需求不斷成長。快速微生物檢測技術有助於快速檢測有害微生物,從而降低污染風險並提高營運效率。人們對感染疾病和產品安全的日益關注也顯著推動了全球市場的擴張。

對品管和法規遵循的日益重視是推動市場發展的主要動力。製藥公司和食品加工企業正擴大採用快速檢測方法,以確保產品安全並滿足嚴格的行業標準。分子診斷、自動化和生物感測器技術的進步也提高了檢測速度、可靠性和實驗室整體效率。

隨著自動化和數位化實驗室解決方案的不斷發展,該市場的未來前景依然十分光明。醫療基礎設施投資的增加以及對即時診斷系統需求的成長預計將進一步推動產業發展。環境監測和臨床診斷領域應用的拓展,預計在未來幾年為快速微生物檢測解決方案提供者帶來巨大的商機。

我們的報告經過精心撰寫,旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分,旨在幫助您全面了解市場環境:

市場概覽:本節對市場進行了清晰的說明,包括關鍵定義、分類以及當前行業格局的概述。

市場動態:對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析:本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局:我們對主要市場參與企業進行了詳細評估,包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測:本部分提供基於數據的市場規模和成長模式預測,預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析,以識別預期的未來趨勢。

區域分析:這包括對主要地理區域的市場表現進行全面檢驗,確定高成長領域和區域趨勢,以更深入地了解每個區域特有的市場機會。

新趨勢與新機會:識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項:我們提供靈活的客製化服務,可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察,從而更有效地支援您的策略決策。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球快速微生物檢測市場:依產品類型分類

  • 市場分析、洞察與預測
  • 消耗品
  • 裝置
  • 試劑和試劑盒

第5章:全球快速微生物檢測市場:依方法分類

  • 市場分析、洞察與預測
  • 利用細胞成分的方法
  • 基於核酸的方法
  • 免疫學
  • 其他方法

第6章 全球快速微生物檢測市場:依應用領域分類

  • 市場分析、洞察與預測
  • 臨床診斷
  • 製藥和生物技術生產中的品管(QC)。
  • 食品和飲料檢查
  • 其他用途

第7章 全球快速微生物檢測市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 臨床實驗室
  • 醫療設施(醫院和即時檢測中心)
  • 食品和飲料公司
  • 製藥和生物技術公司
  • 其他最終用戶

第8章 全球快速微生物檢測市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher ScientificInc
    • Becton, Dickinson & Company
    • Danaher
    • Merck KGaA
    • BioMerieux SA
    • Sartorius AG
    • Charles River Laboratories
    • Bruker Corporation
    • Eurofins Scientific
    • Bio-Rad Laboratories
    • QIAGEN NV
    • IDEXX Laboratories
    • Neogen Corporation
    • Rapid Micro Biosystems
    • Hygiena LLC
簡介目錄
Product Code: VMR112118404

The global rapid microbiology testing market size is expected to reach USD 14.97 Billion in 2034 from USD 6.64 Billion in 2025, growing at a CAGR of 9.45 during 2026-2034.This market is growing steadily due to the increasing demand for faster and more accurate microbial testing solutions across healthcare, food, pharmaceutical, and environmental industries. Rapid microbiology testing technologies help detect harmful microorganisms quickly, reducing contamination risks and improving operational efficiency. Rising concerns regarding infectious diseases and product safety are significantly contributing to market expansion globally.

The growing emphasis on quality control and regulatory compliance is a major driver supporting market development. Pharmaceutical manufacturers and food processing companies are increasingly adopting rapid testing methods to ensure product safety and meet stringent industry standards. Technological advancements in molecular diagnostics, automation, and biosensor technologies are also enhancing testing speed, reliability, and overall laboratory productivity.

Future prospects for the market remain highly promising as automation and digital laboratory solutions continue to evolve. Increasing investments in healthcare infrastructure and rising demand for point-of-care diagnostic systems are expected to strengthen industry growth. Expanding applications in environmental monitoring and clinical diagnostics are likely to create substantial opportunities for rapid microbiology testing solution providers in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

  • Consumables
  • Instruments
  • Reagents & Kits

By Method

  • Cellular Component-Based Methods
  • Nucleic Acid-Based Methods
  • Immunological
  • Other Methods

By Application

  • Clinical Diagnostics
  • Pharmaceutical & Biotech Manufacturing QC
  • Food & Beverage Testing
  • Other Applications

By End User

  • Clinical Laboratories
  • Healthcare Facilities (Hospitals & POC)
  • Food & Beverage Companies
  • Pharma & Biotech Companies
  • Other End Users

COMPANIES PROFILED

  • Thermo Fisher Scientific, Inc., Becton, Dickinson & Company, Danaher, Merck KGaA, bioMerieux SA, Sartorius AG, Charles River Laboratories, Bruker Corporation, Eurofins Scientific, Bio-Rad Laboratories, QIAGEN N.V., IDEXX Laboratories, Neogen Corporation, Rapid Micro Biosystems, Hygiena LLC

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY METHOD 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Method
  • 5.2. Cellular Component-Based Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Nucleic Acid-Based Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Immunological Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Other Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Pharmaceutical & Biotech Manufacturing QC Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Food & Beverage Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Healthcare Facilities (Hospitals & POC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Food & Beverage Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Pharma & Biotech Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Method
    • 8.2.3 By Application
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Method
    • 8.3.3 By Application
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Method
    • 8.4.3 By Application
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Method
    • 8.5.3 By Application
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Method
    • 8.6.3 By Application
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL RAPID MICROBIOLOGY TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher ScientificInc
    • 10.2.2 Becton, Dickinson & Company
    • 10.2.3 Danaher
    • 10.2.4 Merck KGaA
    • 10.2.5 BioMerieux SA
    • 10.2.6 Sartorius AG
    • 10.2.7 Charles River Laboratories
    • 10.2.8 Bruker Corporation
    • 10.2.9 Eurofins Scientific
    • 10.2.10 Bio-Rad Laboratories
    • 10.2.11 QIAGEN N.V
    • 10.2.12 IDEXX Laboratories
    • 10.2.13 Neogen Corporation
    • 10.2.14 Rapid Micro Biosystems
    • 10.2.15 Hygiena LLC